Therapeutic strategies with oral fluoropyrimidine anticancer agent, S-1 against oral cancer
Oral cancer has been recognized as a tumor with low sensitivity to anticancer agents. However, introduction of S-1, an oral cancer agent is improving treatment outcome for patients with oral cancer. In addition, S-1, as a main drug for oral cancer treatment in Japan can be easily available for outpa...
Zapisane w:
| Główni autorzy: | , , |
|---|---|
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
Elsevier
2017-08-01
|
| Seria: | Japanese Dental Science Review |
| Hasła przedmiotowe: | |
| Dostęp online: | http://www.sciencedirect.com/science/article/pii/S1882761616300618 |
| Etykiety: |
Nie ma etykietki, Dołącz pierwszą etykiete!
|